Addressing the ethical and societal challenges posed by genome-wide association studies of behavioral and brain-related traits.
Matthieu C de HemptinneDanielle PosthumaPublished in: Nature neuroscience (2023)
Genome-wide association studies have led to the identification of robust statistical associations of genetic variants with numerous brain-related traits, including neurological and psychiatric conditions, and psychological and behavioral measures. These results may provide insight into the biology underlying these traits and may facilitate clinically useful predictions. However, these results also carry the risk of harm, including possible negative effects of inaccurate predictions, violations of privacy, stigma and genomic discrimination, raising serious ethical and legal implications. Here, we discuss ethical concerns surrounding the results of genome-wide association studies for individuals, society and researchers. Given the success of genome-wide association studies and the increasing availability of nonclinical genomic prediction technologies, better laws and guidelines are urgently needed to regulate the storage, processing and responsible use of genetic data. Also, researchers should be aware of possible misuse of their results, and we provide guidance to help avoid such negative impacts on individuals and society.
Keyphrases
- genome wide association
- genome wide
- case control
- mental health
- copy number
- big data
- white matter
- chronic pain
- decision making
- machine learning
- resting state
- dna methylation
- clinical practice
- mental illness
- gene expression
- social media
- sleep quality
- depressive symptoms
- hiv infected
- human immunodeficiency virus
- functional connectivity